Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA
Recruiting
Phase 4
Interventional Study
Coronary Arterial Disease (CAD)
Angina (Stable)
Microvascular Circulation
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 46 (estimated)
- Sponsor
- VZW Cardiovascular Research Center Aalst · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn whether beta-blockers can improve coronary blood flow and reduce resistance in patients with angina and no obstructive coronary arteries (ANOCA).
The main questions it aims to answer are:
* Do beta-blockers improve coronary blood flow in patients with ANOCA?
* Do beta-blockers reduce coronary microvascular resistance in these patients?
Researchers wil…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients undergoing diagnostic coronary angiography for suspected angina pectoris who are found to have ANOCA i.e. an FFR \>0.80 and no diameter stenosis \>50%
* Normal, TIMI 3 flow at angiography
* Stable haemodynamics
Exclusion Criteria:
* Clinical signs or symptoms of con…
Contacts